Checkpoint Therapeutics (CKPT) disclosed a secondary sale late Monday of up to roughly 5.9 million shares underlying common stock warrants and 351,220 shares underlying placement agent warrants.
The company said the selling shareholders may offer, sell, or distribute the shares at varying prices.
The company will not receive any of the proceeds from the sale.
Company shares were down nearly 5% in after-hours activity.
Price: 2.2100, Change: -0.11, Percent Change: -4.74
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments